BEIJING, Jan. 17, 2022  /PRNewswire/ -- A report from chinadaily.com.cn:  President Xi Jinping delivered a speech at a virtual event of the World Economic Forum on Monday amid anticipation of China's contribution to global economic recovery. This was his third time speaking at the forum as a head of state. Here are some highlights: On China's economy - We have every confidence in the future of China's economy - China's development gains will benefit all its people in a …

HELSINKI, Jan. 18, 2022 /PRNewswire/ -- Picosun takes part as an industrial partner in QuTI, a recently launched extensive research project aiming to develop new components, manufacturing and testing solutions that are needed in quantum technology. Quantum technology has gained interest in a vast array of industries on a large scale. The remarkable performance improvements it offers enable for example powerful computing and benefits in communications, healthcare, sensors, imaging and measurement …

SHANGHAI, Jan. 17, 2022 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter), a subsidiary of Abbisko Cayman Limited (Stock Code: 2256.HK), today announced that it has entered into a worldwide collaboration and exclusive licensing agreement (the "Agreement") with Eli Lilly and Company ("Lilly") for the further discovery, development and potential commercialization of novel molecules against an undisclosed target for cardiometabolic diseases with critical unmet medical …

JAKARTA, Indonesia, Jan. 17, 2022 /PRNewswire/ – JEJALA ID, an initiative by The Ministry of Communications and Informatics of Indonesia, concluded its program series with a hybrid Indonesia Startup Market Insight Seminar and a one-on-one Virtual Matchmaking session at the Expo 2020 Dubai, on January 2-3, 2022. With over 30 Indonesian curated startups exhibited the Indonesian Pavilion at the expo, the program has attracted over 25 investors participants and international visitors from over Singapore, …

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of KE Holdings Inc. ("KE Holdings" or the "Company") (NYSE: BEKE). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether KE Holdings and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Redwire Corporation f/k/a Genesis Park Acquisition Corp. ("Redwire" or the "Company") (NYSE: RDW). Such investors are advised to contact Robert S. Willoughby at  newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Redwire and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Talis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ: TALK). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Talkspace and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Berkeley Lights, Inc. ("Berkeley Lights" or the "Company") (NASDAQ: BLI).  Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Berkeley Lights and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Zhangmen Education Inc. ("Zhangmen" or the "Company") (NYSE: ZME). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Zhangmen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ --  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. ("Ginkgo" or the "Company") (NYSE: DNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Ginkgo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Exicure, Inc. ("Exicure" or the "Company") (NASDAQ: XCUR). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Exicure and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cloopen Group Holding Limited ("Cloopen" or the "Company") (NYSE: RAAS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Cloopen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ("Instadose", "Mikrocoze", or the "Company") (OTCMKTS: INSD; MZKR) and one of its officers. The class action, filed in United States District Court for the Eastern District of Virgina, Norfolk Division, and docketed under 21-cv-00675, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired …

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Robinhood Markets, Inc. ("Robinhood" or the "Company") (NASDAQ: HOOD). Such investors are advised to contact Robert S. Willoughby at  newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Robinhood and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tenet Fintech Group Inc. (f/k/a Peak Fintech Group Inc. ("Tenet" or the "Company") (OTCMKT: PKKFF) (NASDAQ: TNT). Such investors are advised to contact Robert S. Willoughby at  newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Tenet and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of First Solar, Inc. ("First Solar" or the "Company") (NASDAQ: FSLR). Such investors are advised to contact Robert S. Willoughby at  newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether First Solar and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Marathon Digital Holdings, Inc. f/k/a Marathon Patent Group, Inc. ("Marathon" or the "Company") (NASDAQ: MARA) and certain of its officers. The class action, filed in the United States District Court for the District of Nevada, and docketed under 21-cv-02209, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired …

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) and certain of its officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 21-cv-09585, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Revance securities between …

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Goldman Sachs Group Inc. and Morgan Stanley (together, "Defendants") on behalf of investors in iQIYI, Inc. ("iQIYI" or the "Company") (NASDAQ: IQ). The class action, filed in the United States District Court for the Southern District of New York, and docketed under 21-cv-10999, is on behalf of all those investors who purchased or otherwise acquired iQIYI shares contemporaneously …